Millennium Management
GOSS icon

Millennium Management’s Gossamer Bio GOSS Stock Holding History

Millennium Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Buy
30,033
+27,690
+1,182% +$618K ﹤0.01% 4941
2026
Q1 		$61.6K Sell
2,343
-42,461
-95% -$5.34M ﹤0.01% 5410
2025
Q4 		$11.1M Sell
44,804
-438
-1% -$100K ﹤0.01% 2153
2025
Q3 		$9.5M Buy
45,242
+39,039
+629% +$6.88M ﹤0.01% 2436
2025
Q2 		$610K Sell
6,203
-27,272
-81% -$2.38M ﹤0.01% 4764
2025
Q1 		$2.95M Sell
33,475
-11,351
-25% -$1.05M ﹤0.01% 3412
2024
Q4 		$3.24M Buy
44,826
+5,715
+15% +$392K ﹤0.01% 3228
2024
Q3 		$3.09M Sell
39,111
-30,856
-44% -$2.37M ﹤0.01% 3275
2024
Q2 		$5.04M Sell
69,967
-11,226
-14% -$672K ﹤0.01% 2721
2024
Q1 		$7.66M Buy
81,193
+28,385
+54% +$2.5M ﹤0.01% 2440
2023
Q4 		$3.85M Sell
52,808
-35,334
-40% -$2.09M ﹤0.01% 3013
2023
Q3 		$5.87M Buy
88,142
+35,554
+68% +$3.28M ﹤0.01% 2548
2023
Q2 		$5.05M Sell
52,588
-15,667
-23% -$1.56M ﹤0.01% 2662
2023
Q1 		$6.88M Buy
68,255
+10,436
+18% +$1.6M ﹤0.01% 2307
2022
Q4 		$10M Buy
57,819
+41,205
+248% +$27.1M 0.01% 2113
2022
Q3 		$15.9M Sell
16,614
-1,895
-10% -$1.88M 0.01% 1581
2022
Q2 		$12.4M Buy
18,509
+16,338
+753% +$10.1M 0.01% 1775
2022
Q1 		$1.51M Sell
2,171
-440
-17% -$339K ﹤0.01% 4121
2021
Q4 		$2.36M Sell
2,611
-3,749
-59% -$3.56M ﹤0.01% 3617
2021
Q3 		$6.4M Sell
6,360
-1,235
-16% -$910K ﹤0.01% 2585
2021
Q2 		$4.93M Buy
7,595
+7,079
+1,372% +$4.91M ﹤0.01% 2774
2021
Q1 		$382K Sell
516
-1,953
-79% -$1.58M ﹤0.01% 5042
2020
Q4 		$1.91M Sell
2,469
-2,371
-49% -$1.87M ﹤0.01% 3273
2020
Q3 		$4.8M Buy
4,840
+2,353
+95% +$2.5M 0.01% 1883
2020
Q2 		$2.59M Buy
2,487
+979
+65% +$985K ﹤0.01% 2337
2020
Q1 		$1.22M Sell
1,508
-1,101
-42% -$1.15M ﹤0.01% 2340
2019
Q4 		$3.26M Buy
+2,609
New +$4.2M ﹤0.01% 2259
2019
Q2 		– Sell
-252
Closed -$436K – 4192
2019
Q1 		$436K Buy
+252
New +$420K ﹤0.01% 3356

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Millennium Management's GOSS Position: Q2 2026 in Review

Millennium Management increased its Gossamer Bio (GOSS) stake by 1,182% in Q2 2026, buying an estimated $618K and bringing the position to 30,033 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #4941.

Millennium Management first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $15.9M in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Millennium Management held 30,033 shares of Gossamer Bio worth $395K as of Q2 2026.
  • Millennium Management bought 27,690 Gossamer Bio shares in Q2 2026, an estimated $618K.
  • Gossamer Bio made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4941 holding.
  • Millennium Management first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
  • Millennium Management's Gossamer Bio position peaked at $15.9M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.